Heterogeneous treatment effects in stratified clinical trials with time‐to‐event endpoints
From MaRDI portal
Publication:5348691
DOI10.1002/bimj.201600047zbMath1422.62318WikidataQ38927246 ScholiaQ38927246MaRDI QIDQ5348691
Axel Benner, Annette Kopp-Schneider, Christina Beisel, Christina Kunz
Publication date: 18 August 2017
Published in: Biometrical Journal (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1002/bimj.201600047
sample size; Cox proportional hazards model; biomarkers; log-rank test; shared frailty model; trial design
62J05: Linear regression; mixed models
62P10: Applications of statistics to biology and medical sciences; meta analysis
62K05: Optimal statistical designs
62N05: Reliability and life testing
Related Items
Cites Work
- Unnamed Item
- The asymptotic theory of permutation statistics.
- The frailty model.
- Sample-Size Formula for the Proportional-Hazards Regression Model
- Evaluation of Sample Size and Power for Analyses of Survival with Allowance for Nonuniform Patient Entry, Losses to Follow-Up, Noncompliance, and Stratification